| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 03/19/1991 | US5001055 Process for producing physiologically active substance |
| 03/15/1991 | WO1991004025A1 Novel macrocyclic compounds and novel method of treatment |
| 03/15/1991 | CA2065425A1 Macrocyclic compounds and novel method of treatment |
| 03/13/1991 | EP0417033A2 Production of dehydrosine fungin by microorganisms and agricultural use |
| 03/13/1991 | EP0416605A1 Novel oxetanocin derivatives and their salts as well as use thereof |
| 03/13/1991 | EP0416577A2 Method of preparing levoglucosenone |
| 03/12/1991 | CA2025009A1 Antiviral compounds |
| 03/07/1991 | WO1991002739A1 Synthesis of glycosides having predetermined stereochemistry |
| 03/07/1991 | WO1991002736A1 Macrocyclic compounds |
| 03/07/1991 | DE3928900A1 New psoralen-modified nucleotide derivatives - used as anti-sense nucleotide(s) in the treatment of viral infections, e.g. AIDS |
| 03/06/1991 | EP0415901A2 Improved nucleic acid probes |
| 03/06/1991 | EP0415731A2 Novel entities for cancer therapy |
| 03/06/1991 | EP0415018A1 Utilization of adenine nucleotides and/or adenosine and inorganic phosphate for elevation of liver, blood and blood plasma adenosine 5'-triphosphate concentrations |
| 03/06/1991 | EP0414914A1 New substance trehalostatin and production thereof |
| 03/05/1991 | US4997926 Viricides |
| 03/05/1991 | US4997925 Enzyme inhibitors, viricides |
| 03/05/1991 | US4997924 5'-deoxy-4',5'-unsaturated-5'-substituted adenosines |
| 03/05/1991 | US4997820 Microbicides |
| 03/01/1991 | CA2024182A1 Probes |
| 02/27/1991 | CN1049521A Process for prepn. of s'-nucleotide from brewery waste yeast |
| 02/26/1991 | WO1991002725A1 Derivatives of 5-amino-1,2,3,4 tetrahydro-acridine and applications as drugs |
| 02/26/1991 | US4996308 Derivatives with unsaturated substitutions for the 5'-hydroxymethyl group |
| 02/26/1991 | US4996228 Macrolide antibiotics |
| 02/26/1991 | CA2064999A1 1,2,3,4-tetrahydroacridin-5-amine derivatives and their use as therapeutic agents |
| 02/20/1991 | EP0413532A2 Macrocyclic compounds |
| 02/20/1991 | EP0413526A2 Process for preparing 2-deoxy-2, 2-difluoroxylose analogs and intermediates therefor |
| 02/19/1991 | US4994442 Administering liquid mixtures of nutrients, nucleosides and/or nucleotides |
| 02/19/1991 | CA2023485A1 Macrocyclic compounds |
| 02/16/1991 | CA2023224A1 Process for preparing 2-deoxy-2, 2-difluoroxylose analogs and intermediates therefor |
| 02/12/1991 | US4992535 Cardiovascular disorders; side effect reduction |
| 02/12/1991 | US4992534 Anticarcinogenic agents with better water solubility, low toxicity, absorption and stability |
| 02/12/1991 | US4992533 Diagnosing or treating immuno diseases or mucopolysaccharide diseases |
| 02/12/1991 | US4992466 Polycyclic ether antibiotic |
| 02/12/1991 | US4992427 2-substituted inosines and their use as antiviral agents |
| 02/12/1991 | US4992426 Antiparasitic 5'-sulfamoyl nucleosides |
| 02/12/1991 | US4992424 Antiparasitic avermectin derivatives |
| 02/12/1991 | US4992423 Polycyclic ether antibiotics |
| 02/12/1991 | US4992368 Hydrolysis of alkoxylated 2-amino oxetanocina |
| 02/07/1991 | WO1991001325A1 Nucleoside derivatives and their use as medicaments |
| 02/07/1991 | DE4023212A1 New fluorophore-substd. phosphate derivs. - are intermediates for new labelled nucleoside, nucleotide and oligo-nucleotide probes and primers in bio-technology |
| 02/07/1991 | CA2064024A1 Nucleoside derivatives and their use as medicaments |
| 02/05/1991 | US4990606 Stable sulpho-adenosyl-L-methionine (SAMe) salts, particularly suitable for parenteral use |
| 02/05/1991 | US4990499 Treatment of infections and neoplasms |
| 01/31/1991 | DE3924424A1 Nucleosid-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel sowie deren verwendung bei der nucleinsaeure-sequenzierung Nucleoside derivatives, processes for their preparation, their use as medicaments and to their use in nucleic acid sequencing |
| 01/30/1991 | EP0410618A2 Method for visualizing the base sequence of nucleic acid polymers |
| 01/29/1991 | US4988824 Process for the preparation of 23-(C1-C6 alkyloxime)-LL-F28249 compounds |
| 01/24/1991 | WO1991000867A1 5'-diphosphohexose nucleoside pharmaceutical compositions |
| 01/24/1991 | WO1990014831A3 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition |
| 01/24/1991 | WO1990009163A3 Method and compounds for aica riboside delivery and for lowering blood glucose |
| 01/23/1991 | EP0409595A2 Process for the preparation of a carbocyclic nucleoside analogue |
| 01/23/1991 | EP0409575A1 Antiviral pyrimidine nucleosides |
| 01/23/1991 | EP0409227A2 Pyrimidine nucleosides, their preparation and pharmaceutical preparations |
| 01/23/1991 | EP0408727A1 Glycosyl phospholipid nucleoside derivatives and their application as drugs |
| 01/22/1991 | US4987224 Method of preparation of 2',3'-dideoxynucleosides |
| 01/22/1991 | US4987149 Soraphen compounds and their use as microbicides |
| 01/20/1991 | CA2021290A1 Process for the preparation of a carbocyclic nucleoside analogue |
| 01/18/1991 | WO1991001326A1 Antiviral pyrimidine nucleosides |
| 01/18/1991 | CA2065279A1 Antiviral pyrimidine nucleosides |
| 01/16/1991 | EP0407816A2 Base modified nucleosides |
| 01/16/1991 | CN1048496A Aqueous liquid composition for external use |
| 01/15/1991 | US4985409 Adenosine derivatives and pharmaceutical composition thereof |
| 01/15/1991 | CA2021006A1 Base modified nucleosides |
| 01/15/1991 | CA1279063C N-6 substituted adenosine derivatives as cardiac vasodilators |
| 01/15/1991 | CA1279024C Compositions comprising an oligonucleotide sequence linked to an intercalationagent and an activable group, their synthesis and application as artificialsequence specific nucleases |
| 01/09/1991 | EP0406791A2 Aqueous liquid composition for external use |
| 01/09/1991 | EP0406408A1 Antivirals and methods for increasing the antiviral activity of azt |
| 01/09/1991 | EP0406309A1 Oligonucleotide n-alkylphosphoramidates |
| 01/08/1991 | US4983727 Palladium mediated reaction of organic disulfides with mercurated nucleic acid components |
| 01/08/1991 | US4983724 Oxidation, stereoselective reduction with hydride, hydroxy protecting groups |
| 01/08/1991 | US4983609 Anticancer agents |
| 01/08/1991 | US4983586 Pharmaceutical formulations for parenteral use |
| 01/08/1991 | US4983513 Quantitative analysis using lactate dehydrogenase |
| 01/08/1991 | CA1278755C Labelling of oligonucleotides |
| 01/03/1991 | DE3920923A1 Purificn. of nikkomycin(s) X and X - by adsorption on bead copolymers of (meth)acrylic derivs., styrene(s), etc. crosslinked with di- and/or tri-vinyl cpds., e.g. DVB |
| 01/02/1991 | EP0406210A2 Ophthalmic composition |
| 01/02/1991 | CA1278576C2 2-chloro-4,5'-bis(trifluoromethyl)pyridine |
| 01/01/1991 | US4981792 Immunosuppressant compound |
| 12/30/1990 | CA2020085A1 Ophthalmic composition |
| 12/25/1990 | US4980466 Hydrolyzable under mild acid conditions; antibody inhibitors |
| 12/25/1990 | US4980460 Protected nucleosides which permit more efficient oligonucleotide syntheses |
| 12/25/1990 | US4980370 Antiparasitic agents |
| 12/21/1990 | WO1990015812A1 Intermediate for 2-alkynyladenosine synthesis, production of said intermediate, production of 2-alkynyladenosine from said intermediate, and stable 2-alkynyladenosine derivative |
| 12/19/1990 | EP0403242A1 New L-683,590 microbial transformation product |
| 12/19/1990 | EP0402931A1 Heteroatoms-containing tricyclic compounds |
| 12/19/1990 | EP0402752A1 N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments |
| 12/19/1990 | CN1047866A Process for preparation of n-heteroaryl-purin-6-amines and their use as medicaments |
| 12/18/1990 | US4978677 Pesticides |
| 12/18/1990 | US4978675 Macrolide antibiotics and their preparation |
| 12/18/1990 | US4978655 Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses |
| 12/18/1990 | CA1277915C Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2'3' -dideoxycytidine |
| 12/15/1990 | WO1990015805A1 Heteroatoms-containing tricyclic compounds |
| 12/15/1990 | CA2032159A1 Heteroatoms-containing tricyclic compounds |
| 12/13/1990 | WO1990015070A1 Very large scale immobilized peptide synthesis |
| 12/13/1990 | WO1990015064A1 Therapeutic nucleosides |
| 12/13/1990 | WO1990015063A1 Novel thimine derivatives |
| 12/13/1990 | WO1990015062A1 Novel acidic polycyclic ether antibiotics and microorganisms useful in the production thereof |
| 12/13/1990 | WO1990014831A2 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition |
| 12/13/1990 | DE3918898A1 New 2',3'-di:deoxy-ribofuranoside cpds. |
| 12/13/1990 | CA2391491A1 Very large scale immobilized peptide synthesis |
| 12/13/1990 | CA2018710A1 L-683,590 microbial transformation product |